ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $68,576 | -31.4% | 21,633 | +7.5% | 0.00% | – |
Q2 2023 | $100,016 | +4.4% | 20,124 | +3.7% | 0.00% | – |
Q1 2023 | $95,826 | -31.3% | 19,398 | -12.5% | 0.00% | – |
Q4 2022 | $139,518 | -38.0% | 22,181 | +6.2% | 0.00% | -100.0% |
Q3 2022 | $225,000 | -7.4% | 20,884 | -2.2% | 0.00% | 0.0% |
Q2 2022 | $243,000 | -8.6% | 21,359 | -26.9% | 0.00% | 0.0% |
Q1 2022 | $266,000 | -51.5% | 29,221 | -20.5% | 0.00% | 0.0% |
Q4 2021 | $549,000 | -47.7% | 36,775 | -9.9% | 0.00% | -66.7% |
Q3 2021 | $1,050,000 | -11.5% | 40,837 | -10.2% | 0.00% | 0.0% |
Q2 2021 | $1,186,000 | -4.3% | 45,476 | +29.5% | 0.00% | -25.0% |
Q1 2021 | $1,239,000 | +41.1% | 35,111 | +1.0% | 0.00% | +33.3% |
Q4 2020 | $878,000 | -22.8% | 34,779 | +15.3% | 0.00% | -40.0% |
Q3 2020 | $1,137,000 | -4.0% | 30,152 | +9.0% | 0.01% | -16.7% |
Q2 2020 | $1,184,000 | +204.4% | 27,659 | +38.4% | 0.01% | +100.0% |
Q1 2020 | $389,000 | -54.4% | 19,992 | -39.1% | 0.00% | -25.0% |
Q4 2019 | $853,000 | – | 32,842 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |